{"slideshow_credits": null, "snippet": "The drug has been approved by the Food and Drug Administration to treat relapses of a rare blood cancer called mantle cell lymphoma.", "abstract": "Food and Drug Administration approves new drug Imbruvica to treat relapses of a rare blood cancer called mantle cell lymphoma; makers are Pharmacyclics and Johnson & Johnson.", "section_name": "Business Day", "print_page": "7", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/11/14/business/drug-to-treat-blood-cancer-gains-fda-approval.html", "lead_paragraph": "The drug has been approved by the Food and Drug Administration to treat relapses of a rare blood cancer called mantle cell lymphoma.", "headline": {"main": "Imbruvica, Drug to Treat Blood Cancer, Gains F.D.A. Approval", "print_headline": "Drug to Treat Blood Cancer Gains F.D.A. Approval"}, "_id": "52842f1638f0d87725453574", "word_count": "547", "multimedia": [], "pub_date": "2013-11-14T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Food and Drug Administration", "name": "organizations", "is_major": "Y", "rank": "5"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Johnson & Johnson", "name": "organizations", "is_major": "Y", "rank": "8"}, {"value": "Pharmacyclics, Incorporated", "name": "organizations", "is_major": "Y", "rank": "6"}, {"value": "Leukemia", "name": "subject", "is_major": "Y", "rank": "7"}, {"value": "Cancer", "name": "subject", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}